Company Performance Metrics
Mobius Bio develops oncology drug discovery technologies that use live human tissue models rather than traditional animal-based systems. The company integrates artificial intelligence with disease biology to study cancer behavior directly in functional human tissues. Its proprietary wet lab platform analyzes disease mechanisms with clinically
validated relevance to human patients. Mobius Bio focuses on identifying and developing novel anticancer drug candidates that are designed around human biology. Its work targets cancers with limited treatment options by aiming to generate candidates with a higher likelihood of clinical success. The company collaborates across scientific, engineering, and clinical disciplines to advance discovery-stage oncology programs.